The Top Penny Stocks newsletter for active penny stocks investors looking for penny stocks and pink sheet stocks
Richemont chairman Johann Rupert to take 'grey gap... Billionaire 62-year-old to take 12 months off from Cartier and Montblanc luxury goods groupRichemont's chairman and founder Johann Rupert is to take a year off from September, leaving management of the...
Cambodia: aftermath of fatal shoe factory collapse... Workers clear rubble following the collapse of a shoe factory in Kampong Speu, Cambodia, on Thursday
Spate of recent shock departures by 50-something CEOs While the rising financial rewards of running a modern multinational have been well publicised, executive recruiters say the pressures of the job have also been ratcheted upOn approaching his 60th birthday...
UK Uncut loses legal challenge over Goldman Sachs tax... While judge agreed the deal was 'not a glorious episode in the history of the Revenue', he ruled it was not unlawfulCampaign group UK Uncut Legal Action has lost its high court challenge over the legality...
Eurozone crisis live: Japan's strong growth figures... PM Shinzo Abe's stimulus package could generate feelgood factor needed to end two decades of stagnant growthPhillip Inman
LUND, SWEDEN–(Marketwired – Apr 15, 2013) – Active Biotech’s Annual Report 2012 (in
Swedish) is now available for download
at www.activebiotech.com. The English version will be available within
short.
See the rest here: Annual Report 2012 Active Biotech AB (publ)
Category : Stocks, World News
TNI BioTech, Inc. Completes Financial Audit
LUND, SWEDEN–(Marketwire – Mar 28, 2013) – The number of shares and votes in Active
Biotech has changed as a result of the
directed new issue to Investor as previously announced.
Read the original here: Number of shares and votes in Active Biotech
Tips for navigating early-stage investments in biotech
Originally posted here: Lessons from the frontlines of early-stage biotech investing
Wed, Jan 23, 2013 09:59 – BioTech Medics, Inc. (BMCS: OTC Link) released their Quarterly Report concerning Third Qtr – Sept 30, 2012. To read the complete report, please visit: https://www.otciq.com/otciq/ajax/showFinancialReportById.pdf?id=98314.
Excerpt from: BioTech Medics, Inc. (BMCS: OTC Link) | Quarterly Report
Category : Stocks
CLEVELAND [January 2] /PRNewswire/ — DATATRAK International, Inc. (OTCQX: DATA), a leader in developing cloud-based, unified eClinical™ technologies and delivering related services for the clinical trials industry, today announced its participation at industry events during the month of January.
The 6th Annual OneMedForum
San Francisco, CA
January 7 – 9, 2013
The 6th Annual OneMedForum is a gathering of leading investors and management of emerging life sciences companies in Asia and North America to explore strategies for company growth finance with healthcare investors.
Biotech Showcase
San Francisco, CA
January 7 – 9, 2013
Biotech Showcase™ is an investor and partnering conference devoted to providing private and public biotechnology and life sciences companies an opportunity to present to, and meet with, investors and pharmaceutical executives.
About DATATRAK
DATATRAK is the leader of unified eClinical™ technologies and related services for the clinical trials industry.
Achievements Recognized in the Categories of Leading Companies, Outstanding Individuals, and Scientific Achievements by Biotech Industry CEOs
See the original post: New Inductees to The Biotech Meeting Hall of Fame Announced
Category : Stocks
LEIDEN, THE NETHERLANDS–(Marketwire – Aug 20, 2012) – Biotech company Pharming Group NV
(“Pharming” or “the Company”) (NYSE Euronext: PHARM) today announces that
the
investors have increased the first call under the facility by 16,440,148
shares
from 45,808,442 to 62,248,590.
Here is the original post: Pharming Updates on Ongoing Call of First Tranche of EUR10 Million Equity Working Capital Facility
Category : Stocks
Marina Biotech Announces Worldwide Non-Exclusive Licensing Agreement for Nucleic Acid Chemistry < ?xml:namespace prefix = o ns = "urn:schemas-microsoft-com:office:office" />
Bothell, WA, August 3, 2012 – Marina Biotech, Inc. (OTCQX: MRNA), a leading nucleic acid-based drug discovery and development company, announced today that it has entered into a licensing agreement with Novartis for Marina Biotech’s Conformationally Restricted Nucleotide (CRN) technology for the development of both single- and double-stranded oligonucleotide therapeutics.
CRTX PSDV OCLR IMMU DNDN AUTH BSDM PLX WINDERMERE, Fla. (Stockpickr) — At Stockpickr, we track daily portfolios of stocks that are the biggest percentage gainers and the biggest percentage losers.
Stocks that are making large moves like these are favorites among short-term traders because they can jump into these names and try to capture some of that massive volatility. Stocks that are making big-percentage moves either up or down are usually in play because their sector is becoming attractive or they have a major fundamental catalyst such as a recent earnings release. Sometimes stocks making big moves have been hit with an analyst upgrade or an analyst downgrade.
>>5 Hated Stocks Set to Soar on Earnings …
Click to view a price quote on CRTX.
Click to research the Drugs industry.
View post: 4 Biotech Stocks Under $10 With Relative Strength